COMP <GO>
EMR vs TSM // OPERATING MARGIN
Emerson Electric Company (NYSE) VS. Taiwan Semiconductor Manufacturing Company Ltd. (NYSE) • 15-METRIC TALLY: EMR 5
— TSM 9
▲ OPERATING MARGIN LEADER: TSM
LAST: $164.94 (-3.40%) • MKT CAP: $95.24B
operating-margins
15.50%
LAST: $406.13 (-5.95%) • MKT CAP: $2.24T
operating-margins
21.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMR VS. TSM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMR | TSM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 52.80% | 62.00% | -9.20 | TSM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.70% | 14.90% | -5.20 | TSM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 30.9x | 14.9x | +16.00 | TSM | /valuation <GO> |
| Free Cash Flow Yield | 2.80% | 3.99% | -1.19 | TSM | /fcf-yield <GO> |
| Operating Margin ACTIVE | 15.50% | 21.10% | -5.60 | TSM | /operating-margins <GO> |
| Net Profit Margin | 12.70% | 16.40% | -3.70 | TSM | /net-margins <GO> |
| Revenue Growth (YoY) | 3.00% | -3.30% | +6.30 | EMR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.25% | 0.00% | +1.25 | EMR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.80 | 3.87 | +0.93 | EMR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 8.10% | 8.30% | -0.20 | EMR | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.5 | 38.3 | +18.17 | EMR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.34 | 1.42 | -0.08 | TSM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 38.6x | 20.2x | +18.40 | TSM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $95.24B | $2.24T | -$2.14T | TSM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMR REV | TSM REV | EMR GROSS % | TSM GROSS % | EMR FCF | TSM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.02B | — | 52.8% | — | $2.67B | — |
| FY 2024 | $17.49B | — | 50.8% | — | $2.91B | — |
| FY 2023 | $15.16B | — | 44.0% | — | -$45.4M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMR // BETA 1.34
TSM // BETA 1.42